Editas Medicine, an upstart hoping to treat patients by correcting their genes, went public yesterday. But the company already faces several concerns---most pressingly, a patent battle.
The post Crispr Gene-Editing Upstart Editas Goes Public as Patent Battle Rages appeared first on WIRED.
This is a controversial first step toward what some see as a future of designer babies. But it doesn't go nearly that far.
The post The UK Just Green-Lit Crispr Gene Editing in Human Embryos appeared first on WIRED.
If you’re hoping to engineer perfect babies, you’re going to have to wait.
The post Crispr Gene-Editing Gets Rules. Well, Guidelines, Really appeared first on WIRED.
When Chinese scientists announced in April they had edited human embryos using a new genetic tool called Crispr, the headlines blared “designer babies” and the wider world woke up to Crispr’s power.
The post Crispr Is Getting Better. Now It’s Time to Ask the Hard Ethical Questions appeared first on WIRED.
How gene drives force a gene to spread through a population.
The post The ‘Gene Drive’ That Builds a Malaria-Proof Mosquito appeared first on WIRED.
One of the main biotechs hoping to capitalize on the powerful gene-editing system called Crispr-Cas9 is squatting on the Twitter handles most directly associated with the technology.
The post The Battle Over Crispr Rights Is Playing Out on Twitter Too appeared first on WIRED.
Scientists have found a second CRISPR system that can edit human DNA.
The post The War Over Genome Editing Just Got a Lot More Interesting appeared first on WIRED.